SYTL4 downregulates microtubule stability and confers paclitaxel resistance in triple-negative breast cancer

Background: Taxanes are frontline chemotherapeutic drugs for patients with triple-negative breast cancer (TNBC); however, chemoresistance reduces their effectiveness. We hypothesized that the molecular profiling of tumor samples before and after neoadjuvant chemotherapy (NAC) would help identify gen...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Theranostics
मुख्य लेखकों: Liu, Xi-Yu, Jiang, Wang, Ma, Ding, Ge, Li-Ping, Yang, Yun-Song, Gou, Zong-Chao, Xu, Xiao-En, Shao, Zhi-Ming, Jiang, Yi-Zhou
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Ivyspring International Publisher 2020
विषय:
Research Paper
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC7532662/
https://ncbi.nlm.nih.gov/pubmed/33042263
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.45207
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन